Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Pathogenicity of exonic indels in fused in sarcoma in amyotrophic lateral sclerosis.

Rutherford NJ, Finch NA, DeJesus-Hernandez M, Crook RJ, Lomen-Hoerth C, Wszolek ZK, Uitti RJ, Graff-Radford NR, Rademakers R.

Neurobiol Aging. 2012 Feb;33(2):424.e23-4. doi: 10.1016/j.neurobiolaging.2010.09.029.

2.

Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.

Ito D, Suzuki N.

Neurology. 2011 Oct 25;77(17):1636-43. doi: 10.1212/WNL.0b013e3182343365. Review.

3.
4.

RNA-binding proteins and RNA metabolism: a new scenario in the pathogenesis of Amyotrophic lateral sclerosis.

Colombrita C, Onesto E, Tiloca C, Ticozzi N, Silani V, Ratti A.

Arch Ital Biol. 2011 Mar;149(1):83-99. doi: 10.4449/aib.v149i1.1261. Review.

PMID:
21412718
5.

How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?

Baloh RH.

Curr Opin Neurol. 2012 Dec;25(6):701-7. doi: 10.1097/WCO.0b013e32835a269b. Review.

PMID:
23041957
6.

TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.

Lattante S, Rouleau GA, Kabashi E.

Hum Mutat. 2013 Jun;34(6):812-26. doi: 10.1002/humu.22319. Review.

PMID:
23559573
7.

Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.

Neumann M.

Rev Neurol (Paris). 2013 Oct;169(10):793-8. doi: 10.1016/j.neurol.2013.07.019. Review.

PMID:
24011641
8.

TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?

Strong MJ, Volkening K.

FEBS J. 2011 Oct;278(19):3569-77. doi: 10.1111/j.1742-4658.2011.08277.x. Review.

Supplemental Content

Support Center